|
1
|
Barker AF, Bergeron A, Rom WN and Hertz
MI: Obliterative bronchiolitis. N Engl J Med. 370:1820–1828.
2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Au BK, Au MA and Chien JW: Bronchiolitis
obliterans syndrome epidemiology after allogeneic hematopoietic
cell transplantation. Biol Blood Marrow Transplant. 17:1072–1078.
2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hogg JC, Pare PD and Hackett TL: The
contribution of small airway obstruction to the pathogenesis of
chronic obstructive pulmonary disease. Physiol Rev. 97:529–552.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sarria EE, Mundstock E, Machado DG,
Mocelin HT, Fischer GB, Furlan SP, Antonello ICF, Stein R,
Mattiello R, et al: Health-related quality of life in patients with
bronchiolitis obliterans. J Pediatr (Rio J). 94:374–379.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Moonnumakal SP and Fan LL: Bronchiolitis
obliterans in children. Curr Opin Pediatr. 20:272–278.
2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Murtagh P, Giubergia V, Viale D, Bauer G
and Pena HG: Lower respiratory infections by adenovirus in
children. Clinical features and risk factors for bronchiolitis
obliterans and mortality. Pediatr Pulmonol. 44:450–456.
2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jerkic SP, Brinkmann F, Calder A, Casey A,
Dishop M, Griese M, Kurland G, Niemitz M, Nyilas S, Schramm D, et
al: Postinfectious bronchiolitis obliterans in children: Diagnostic
workup and therapeutic options: A workshop report. Can Respir J.
2020(5852827)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Smith KJ and Fan LL: Insights into
post-infectious bronchiolitis obliterans in children. Thorax.
61:462–463. 2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Colom AJ, Teper AM, Vollmer WM and Diette
GB: Risk factors for the development of bronchiolitis obliterans in
children with bronchiolitis. Thorax. 61:503–506. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Rosewich M, Zissler UM, Kheiri T, Voss S,
Eickmeier O, Schulze J, Herrmann E, Dücker RP, Schubert R and
Zielen S: Airway inflammation in children and adolescents with
bronchiolitis obliterans. Cytokine. 73:156–162. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Colom AJ and Teper AM: Post-infectious
bronchiolitis obliterans. Pediatr Pulmonol. 54:212–219.
2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Champs ND, Lasmar LMLBF, Camargos PAM,
Marguet C, Fischer GB and Mocelin HT: Post-infectious bronchiolitis
obliterans in children. J Pediat-Brazil. 87:187–198. 2011.(In
English, Portuguese).
|
|
13
|
Tomikawa SO, Adde FV, da Silva Filho LV,
Leone C and Rodrigues JC: Follow-up on pediatric patients with
bronchiolitis obliterans treated with corticosteroid pulse therapy.
Orphanet J Rare Dis. 9(128)2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Moran TJ and Hellstrom HR: Bronchiolitis
obliterans: An experimental study of the pathogenesis and the use
of cortisone in modification of the lesions. AMA Arch Pathol.
66:691–707. 1958.PubMed/NCBI
|
|
15
|
Ratjen F, Rjabko O and Kremens B:
High-dose corticosteroid therapy for bronchiolitis obliterans after
bone marrow transplantation in children. Bone Marrow Transplant.
36:135–138. 2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bergeron A, Chevret S, Chagnon K, Godet C,
Bergot E, Peffault de Latour R, Dominique S, de Revel T, Juvin K,
Maillard N, et al: Budesonide/Formoterol for bronchiolitis
obliterans after hematopoietic stem cell transplantation. Am J
Respir Crit Care Med. 191:1242–1249. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kim SW, Rhee CK, Kim YJ, Lee S, Kim HJ and
Lee JW: Therapeutic effect of budesonide/formoterol, montelukast
and N-acetylcysteine for bronchiolitis obliterans syndrome after
hematopoietic stem cell transplantation. Respir Res.
17(63)2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li YN, Liu L, Qiao HM, Cheng H and Cheng
HJ: Post-infectious bronchiolitis obliterans in children: A review
of 42 cases. BMC Pediatr. 14(238)2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sobande PO and Kercsmar CM: Inhaled
corticosteroids in asthma management. Respir Care. 53:625–634.
2008.PubMed/NCBI
|
|
20
|
Elliot ER, Theodoraki A, Jain LR, Marshall
NJ, Boffito M, Baldeweg SE and Waters LJ: Iatrogenic Cushing's
syndrome due to drug interaction between glucocorticoids and the
ritonavir or cobicistat containing HIV therapies. Clin Med (Lond).
16:412–418. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Dalby C, Polanowski T, Larsson T,
Borgstrom L, Edsbacker S and Harrison TW: The bioavailability and
airway clearance of the steroid component of budesonide/formoterol
and salmeterol/fluticasone after inhaled administration in patients
with COPD and healthy subjects: A randomized controlled trial.
Respir Res. 10(104)2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Williams KM: How I treat bronchiolitis
obliterans syndrome after hematopoietic stem cell transplantation.
Blood. 129:448–455. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Verleden GM, Vos R, Dupont L, Van
Raemdonck DE, Vanaudenaerde BM and Verleden SE: Are we near to an
effective drug treatment for bronchiolitis obliterans? Expert Opin
Pharmaco. 15:2117–2120. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Williams KM, Cheng GS, Pusic I, Jagasia M,
Burns L, Ho VT, Pidala J, Palmer J, Johnston L, Mayer S, et al:
Fluticasone, azithromycin, and montelukast treatment for new-onset
bronchiolitis obliterans syndrome after hematopoietic cell
transplantation. Biol Blood Marrow Transplant. 22:710–716.
2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Norman BC, Jacobsohn DA, Williams KM, Au
BK, Au MA, Lee SJ, Moravec CK and Chien JW: Fluticasone,
azithromycin and montelukast therapy in reducing corticosteroid
exposure in bronchiolitis obliterans syndrome after allogeneic
hematopoietic SCT: A case series of eight patients. Bone Marrow
Transplant. 46:1369–1373. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gottlieb J, Szangolies J, Koehnlein T,
Golpon H, Simon A and Welte T: Long-term azithromycin for
bronchiolitis obliterans syndrome after lung transplantation.
Transplantation. 85:36–41. 2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Verleden GM, Verleden SE, Vos R, De
Vleeschauwer SI, Dupont LJ, Van Raemdonck DE and Vanaudenaerde BM:
Montelukast for bronchiolitis obliterans syndrome after lung
transplantation: A pilot study. Transpl Int. 24:651–656.
2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nguyen TT, Hoo AF, Lum S, Wade A, Thia LP
and Stocks J: New reference equations to improve interpretation of
infant lung function. Pediatr Pulmonol. 48:370–380. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Murphy KR, Zeiger RS, Kosinski M, Chipps
B, Mellon M, Schatz M, Lampl K, Hanlon JT and Ramachandran S: Test
for respiratory and asthma control in kids (TRACK): A
caregiver-completed questionnaire for preschool-aged children. J
Allergy Clin Immunol. 123:833–839.e9. 2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Liu AH, Zeiger R, Sorkness C, Mahr T,
Ostrom N, Burgess S, Rosenzweig JC and Manjunath R: Development and
cross-sectional validation of the childhood asthma control test. J
Allergy Clin Immunol. 119:817–825. 2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Diemert DJ: Prevention and self-treatment
of traveler's diarrhea. Clin Microbiol Rev. 19:583–594.
2006.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ruttens D, Verleden SE, Vandermeulen E,
Bellon H, Vanaudenaerde BM, Somers J, Schoonis A, Schaevers V, Van
Raemdonck DE, Neyrinck A, et al: Prophylactic azithromycin therapy
after lung transplantation: Post hoc analysis of a randomized
controlled trial. Am J Transplant. 16:254–261. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wang X, Liu C, Wang M, Zhang YI, Li H and
Liu G: Clinical features of post-infectious bronchiolitis
obliterans in children undergoing long-term azithromycin treatment.
Exp Ther Med. 9:2379–2383. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Verleden GM, Vanaudenaerde BM, Dupont LJ
and Van Raemdonck DE: Azithromycin reduces airway neutrophilia and
interleukin-8 in patients with bronchiolitis obliterans syndrome.
Am J Respir Crit Care Med. 174:566–570. 2006.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Okunishi K and Peters-Golden M:
Leukotrienes and airway inflammation. Biochim Biophys Acta.
1810:1096–1102. 2011.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Bevacqua BK: Pre-operative pulmonary
evaluation in the patient with suspected respiratory disease.
Indian J Anaesth. 59:542–549. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Fuchs O, Latzin P, Thamrin C, Stern G,
Frischknecht P, Singer F, Kieninger E, Proietti E, Riedel T and
Frey U: Normative data for lung function and exhaled nitric oxide
in unsedated healthy infants. Eur Respir J. 37:1208–1216.
2011.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Schmalisch G, Wilitzki S and Wauer RR:
Differences in tidal breathing between infants with chronic lung
diseases and healthy controls. BMC Pediatr. 5(36)2005.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Chen J, Liu X, Du W, Srivastava R, Fu J,
Zheng M, Zhou J and McGrath E: Pulmonary function testing in
pediatric pneumonia patients with wheezing younger than 3 years of
age. Global pediatric health. 6(2333794X19840357)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
O'Donnell DE, Elbehairy AF, Berton DC,
Domnik NJ and Neder JA: Advances in the evaluation of respiratory
pathophysiology during exercise in chronic lung diseases. Front
Physiol. 8(82)2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Fiorino S, Bacchi-Reggiani L, Detotto E,
Battilana M, Borghi E, Denitto C, Dickmans C, Facchini B, Moretti
R, Parini S, et al: Efficacy of non-invasive mechanical ventilation
in the general ward in patients with chronic obstructive pulmonary
disease admitted for hypercapnic acute respiratory failure and
pH<7.35: A feasibility pilot study. Intern Med J. 45:527–537.
2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Williams KM, Cheng GS, Pusic I, Jagasia M,
Burns L, Ho VT, Pidala J, Palmer J, Johnston L, Mayer S, et al:
Fluticasone, Azithromycin, and montelukast treatment for new-onset
bronchiolitis obliterans syndrome after hematopoietic cell
transplantation. Biol Blood Marrow Transplant. 22:710–716.
2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ranu H, Wilde M and Madden B: Pulmonary
function tests. Ulster Med J. 80:84–90. 2011.PubMed/NCBI
|
|
44
|
Zhang XM, Lu AZ, Yang HW, Qian LL, Wang LB
and Zhang XB: Clinical features of postinfectious bronchiolitis
obliterans in children undergoing long-term nebulization treatment.
World J Pediatr. 14:498–503. 2018.PubMed/NCBI View Article : Google Scholar
|
